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Abstract
The Varsity Medical Debate, between Oxford and Cambridge Universities, brings together practitioners and the public, 
professors, pupils and members of the polis, to facilitate discussion about ethics and policy within healthcare. The 
motion on privatizing the National Health Service (NHS) was specifically chosen to reflect the growing sentiment in the 
UK where further discourse upon models of healthcare was required. Time and again, the outcome of British elections 
pivots upon the topic of financial sustainability of the NHS. Having recently celebrated its sixtieth anniversary, the NHS 
has become heavily politicized in recent months, especially in the aftermath of the devastating global recession.
Background
The 2010 Varsity Medical Debate between historical
rivals Cambridge and Oxford Universities took place at
the Royal College of General Practitioners in London on
the 22nd January. The debate was overseen by a presti-
gious panel of judges including the President of the Col-
lege, Dr Iona Heath, and the former President of the
Royal Society of Medicine, Baroness Finlay of Llandaff.
Representatives from Oxford University proposed the
motion that "This House would Privatize the Provision of
Healthcare" and put forward the case for a privatized
model, built upon an amalgamation of successful interna-
tional frameworks (as seen in Appendix 1 [1]), to replace
the secondary and tertiary care sectors in the ageing
NHS. The motion was opposed by representatives from
Cambridge University who argued that improving the
publicly funded status quo was still plausible and prefera-
ble.
Since 1997, NHS expenditure has more than doubled
from £35 billion to £89 billion [2]. However, a soaring def-
icit estimated at £3 billion per year has prompted many to
question how much longer the current socialized system
can be sustained. The 2006 Herceptin scandal is an exam-
ple of the sensitive nature of any discussion of healthcare
financing issues. Initially chemotherapy for breast cancer
using this agent was not approved by the National Insti-
tute of Clinical Excellence (NICE) for public access due to
its high cost. However, patient appeals to the High Court
compelled NICE to reverse its initial decision [3]. Future
controversy is undoubtedly inevitable as the NICE
threshold of £20-30,000 per Quality-Adjusted Life Year
(QALY) gained is tested by an ever more expensive array
of drugs [4]. Other recent examples include the arthritis
drug RoActemra and the cancer drug Nexavar; both of
which are currently unavailable in England on grounds of
unqualified cost-effectiveness: although an appeal against
the Nexavar ruling is set to take place later this month [5].
Many argue that we are already proceeding toward a
semi-privatized model with Private Finance Initiative
(PFI) based hospitals and encroachment of service provi-
sion by Independent Sector Treatment Centres (ISTC),
thereby blurring the line between private and govern-
mental funding. It was in this context that the 2010
debate engaged a range of viewpoints on healthcare
privatization. The issues discussed in the debate were
delineated across key themes including economics,
patient choice and ethics.
Proposition's Privatized Prototype
Oxford proposed a model in which the role of the state as
a regulator of care was distinguished from its role as a
provider. An income tax-funded voucher scheme based
upon a model suggested in the USA [6] would be used to
purchase health insurance. Private companies could then
competitively offer a variety of packages to suit individual
needs. The basic state package would cost the minimum
voucher price and patients would have the choice of
increasing payment coverage to access additional ser-
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vices, such as private diagnostic scans. Crucially, the state
would provide risk equalization subsidies to insurance
companies to ensure competitive uptake of high-risk
patients. Hospitals would be privately run and reputable
companies would benefit from franchising to provide
sub-specialty care. Primary care and acute emergency
services would nevertheless remain state-provided.
Economic and political implications
The Oxford team began their proposition by highlighting
a range of factors that they believed made the current
NHS unsustainable. Chief among these was increasing
costs amidst decreasing efficiency. Oxford insisted that
with a national debt of over £178 billion [7], crippling real
term cuts to the current healthcare system were simply
unavoidable.
Oxford claimed that their model would reduce costs
and increase quality of care. This rested heavily on the
belief that market forces and competition would signifi-
cantly encourage efficiency. It was also stated that current
government targets skew incentives so that arbitrary
goals are met at the expense of quality of care. In the pro-
posed model, risk equalization subsidies and competition
between hospitals for patients would produce favorable
clinical outcomes.
Cambridge strongly objected to the labeling of existing
targets as arbitrary. They claimed that such targets did
accurately reflect clinical outcomes and illustrated their
point using the example of preventative blood pressure
checks to ensure that patients at risk of heart attack and
stroke are prophylactically maintained on statins. Fur-
thermore, a comparison was made to the US' private
healthcare system, where health indicators such as infant
mortality are worse than in the UK, despite a significantly
increased per capita expenditure [8]. Cambridge argued
that reduced cost was neither an inherent nor guaranteed
benefit of private healthcare.
Patient Choice
A central tenet of the Oxford model was the enhanced
fairness that would result from greater patient choice.
Their reasons for this premise were two-fold: first, the
availability of private healthcare separate from NHS
treatment suggested that British society had accepted
that those who earned more could purchase better care.
Moreover, they believed that there was a philosophical
justification for this, in that removing the advantages of
wealth removes the point of accumulating wealth, and
thus removes productivity incentives in a capitalist soci-
ety. Second, rather than just NHS and private options
top-ups allow greater flexibility and accessibility to those
who want to increase the quality of care according to
both their health priorities and their earnings.
Oxford also highlighted that by choosing their health-
care packages, patients would assume more responsibility
over their personal well-being. The very act of choosing
insurance would not only compel them to consider the
extent of health care afforded, but would also empower
patients to recognize the limitations imposed by and
upon their lifestyle. Additionally, the payment of premi-
ums could incentivize patients to deter those lifestyle
choices that have a negative impact on health (such as
smoking and high-cholesterol diets).
Cambridge responded by asserting that increased
choice, while beneficial, should not come at the heavy
cost of access to healthcare. They claimed that lower
social classes would have reduced availability to more
complex and expensive interventions that require unaf-
fordable top-ups. In addition, financially incentivizing
patients to change their health behaviors could have a
disastrous impact on chronic disease management. In
such cases, patients would delay seeking medical advice,
and this would lead to exacerbation of existing pathology,
worsening of signs and symptoms, poorer prognoses, and
eventually increased expenditure. Ultimately, the
patients' access to healthcare provision should not be
determined by their ability to afford it.
Ethical considerations
A fundamental aspect of the Cambridge counter-argu-
m e n t  w a s  t o  i d e n t i f y  a c c e s s  t o  h e a l t h c a r e  a s  a  b a s i c
human right. If a population is concerned about securing
the civil liberties of all citizens, then a commitment
should be made to ensure that the quality of life of the
indi vidua l is  a deq ua t e  t o  m a k e  m os t  o f  t hese  libe rt ies.
Healthcare is instrumental, if not crucial, to quality of life.
Cambridge was suspicious of the motives adopted by pri-
vate companies, working from the presumption that if the
raison d'être of these companies was to maximize profit,
then quality and fairness would improve only for as long
as financial gain was forecasted.
Oxford contended that even if healthcare was a right, it
could be delivered more efficiently by the market and
illustrated this by a comparison with the food industry; a
clear example of market forces operating to increase effi-
ciency and to keep food prices consistently low, while
c a t e r i n g  t o  c o n s u m e r  c h o i c e ( s ) .  R e s t  a s s u r e d ,  n o  o n e
attempted to compare patients to produce, yet the poten-
tial benefits evoked by the ideology of greater choice were
well depicted.
Conclusion
After much deliberation, the judges narrowly awarded
victory to Oxford. Dr Heath praised the effort and debat-
ing skill of all participants and reiterated the importance
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point that was raised throughout the debate was the allo-
cation of limited national resources. Cost, access and
quality of care are all vital, but improvements in one fac-
tor may come at the expense of another . Oxford's view
was that decreasing access to non-essential care services
for a small minority would result in a disproportionate
benefit in cost, access and quality for the majority. Cam-
bridge's view was that access was paramount. Ultimately,
what is important are the values and views of society. Sur-
veys consistently show that the British public are still
overwhelmingly in favor of free health service and echo
the 'from cradle to grave' philosophy, or rather yet 'from
womb to tomb' nowadays, of healthcare provision. Nev-
ertheless, it is clear that crucial changes and stricter legis-
l a t i o n  w i l l  b e  r e q u i r e d  i n  t h e  c o m i n g  y e a r s .  B o t h  t h e
administrative and financial infrastructure of the NHS
must be sustainable in times of economic and political
flux if the system is to cope with the needs and demands
of an aging population, greater immigration and ever
more costly market.
It was encouraging to see both the enthusiasm of the
multi-disciplinary audience members, and versatility of
the debaters in critically discussing and engaging contro-
versial issues despite the relatively early stage of their pro-
fessional training. In the end, it was unanimously agreed
that today's students will ultimately have a most difficult,
and the most crucial role in shaping tomorrow's NHS.
Appendix 1
Modern healthcare delivery is mainly categorized in the
following four sectors [1]:
A. Socialized medicine (e.g. UK) which is funded by the
state.
B. Socialized insurance (e.g. France) which provides
services for fees.
C. Mandatory insurance (e.g. Germany) which relies on
multiple sickness funds.
D. Voluntary insurance (e.g. USA) which depends on
private and commercialized companies offering services
for fees through various packages.
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